SATO Yuji 佐藤裕二

Researcher Number	60261286
Other IDs
Affiliation (based on the past Project Information) *help	2005: Hokkaido Univ., Grand.School of Med.1, Visiting researcher, 大学院・医学研究科, 客員研究員 2003 – 2004: 北海道大学, 大学院・医学研究科, 助教授
Review Section/Research Field	Principal Investigator Digestive surgery Except Principal Investigator Digestive surgery
Keywords	Principal Investigator cytokine / deletion of MHC-class I / paraffin-embeded specimen / frozen specimen / scirrhous type / gastric cancer / immunohistochemistry / MHC-class I / frozen speimen / リンパ球表面抗原 / 腫瘍特異抗原 / 免疫能 / MHC分子 … More Except Principal Investigator … More iNOS / p21 / CD-DST / インターフェロン / 大腸癌肝転移 Less

Study of prognostic prediction in stage III and IV gastric carcinoma by immunological evaluationPrincipal Investigator
- Principal Investigator
  
  SATO Yuji
- Project Period (FY)
  2004 – 2005
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Digestive surgery
- Research Institution
  HOKKAIDO UNIVERSITY
大腸癌肝筋移に対するインターフェロンβ geneを用いた免疫療法の開発
- Principal Investigator
  
  KONDO Masao
- Project Period (FY)
  2003 – 2005
- Research Category
  
  Grant-in-Aid for Exploratory Research
- Research Field
  
  Digestive surgery
- Research Institution
  Hokkaido University

All 2006 2005 2004

All Journal Article

[Journal Article] Chemotheapy prediction in esopphageal cell carcinoma : Novel marker genes and efficacy-prediction formulae using expression data.2006
- Author(s)
  Shimokuni T, Tanimoto K, Hiyama K, Otani K, Ohtaki M, Hihara J, Yoshida K, Noguchi T, Kawahara K, Natsugoe S, Aikou T, Okazaki Y, Hayashizaki Y, Sato Y, Todo S, Hiyama E, Nishiyama M
- Journal Title
  
  Int J Oncol 28
  
  Pages: 1153-1162
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-16591286
[Journal Article] Chemotheapy Prediction in esophageal cell carcinoma : Novel marker genes and efficacy-prediction formulae using expression data.2006
- Author(s)
  Shimokuni T, Tanimoto K, Hiyama K, Otani K, Ohtaki M, Hihara J, Yoshida K, Noguchi T, Kawahara K, Natsugoe S, Aikou T, Okazaki Y, Hayashizaki Y, Sato Y, Todo S, Hiyama E, Nishiyama M
- Journal Title
  
  Int J Oncol 28
  
  Pages: 1153-1162
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-16591286
[Journal Article] Phase II study of Docetaxel and S-1 combination therapy for advanced or recurrent gastric cancer.2006
- Author(s)
  Yoshida K, Ninomiya M, Takakura N, Hirabayashi N, Takiyama W, Sato Y, Todo S, Terashima M, Goto M, Sakamoto J, Nishiyama M
- Journal Title
  
  Clin.Cancer Res (in press)
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-16591286
[Journal Article] squamous cell carcinoma antigen- reactive CTLs in HLA-A24+ cancer patient.2006
- Author(s)
  Honnma S, Harada M, Yano H, Ogasawara S, Shichijo S, Matsueda S, Komatau N, Shomura H, Maeda Y, Sato Y, Todo S, Itoh K : Indentification of
- Journal Title
  
  International J Oncol. In press
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-16591286
[Journal Article] Identification of squamous cell carcinoma antigen-reactive CTLs in HLA-A24+ cancer patient.2006
- Author(s)
  Homma S, Harada M, Yano H, Ogasawara S, Shichijo S, Matsueda S, Komatsu N, Shomura H, Maeda Y, Sato Y, Todo S, Itoh K
- Journal Title
  
  International J Oncol. (in press)
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-16591286
[Journal Article] Phase II study of Docetaxel and S-1 combination therapy for advanced or recurrent gastric cancer. 2006, in press2006
- Author(s)
  Yoshida K, Ninomiya M, Takakura N, Hirabayashi N, Takiyama W, Sato Y, Todo S, Terashima M, Goto M, Sakamoto J, Nishiyama M
- Journal Title
  
  Clin, Cancer Res In press
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-16591286
[Journal Article] Evidence of dual function of macrophage migration factor relevant to tumor progression and regression.2005
- Author(s)
  Fukushima T, Nishihira J, Yoshiki T, Iwabuchi K, Iwabuchi C, Yamasaki Y, Kondo M, Sun B, Sato Y, Todo S
- Journal Title
  
  Int.J. Molecular Medicine. 16(1)
  
  Pages: 119-126
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-16591286
[Journal Article] Macrophage Migration Inhibitory Factor (MIF) promotes tumor invation and metastasis via the Rho-Dependent pathway.2005
- Author(s)
  Sun B, Nishihira J, Yoshiki T, Kondo M, Sato Y, Sasaki F, Todo S
- Journal Title
  
  Clinical Cancer Research 11
  
  Pages: 1050-1058
- Data Source
  KAKENHI-PROJECT-16591286
[Journal Article] Evidence of dual function of macrophage migration factor relevant to tumor progression and regression.2005
- Author(s)
  Fukushima T, Nishihira J, Yoshiki T, Iwabuchi K, Iwabuchi C, Yamasaki Y, Kondo M, Sun B, Sato Y, Todo S
- Journal Title
  
  Int.J.Molecular Medicine. 16(1)
  
  Pages: 119-126
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-16591286
[Journal Article] Humoral Response to peptide correlate with over all survival in advanced cancer patients vaccinated with peptides based on pre-existing, peptide-specific cellular responses.2004
- Author(s)
  Mine T, Sato Y, Noguchi M, Sasatomi T, Gouhara R, Tsuda N, Tanaka S, Shoumura H, Katagiri K, Rikimaru T, Shichijo S, Kamura T, Hashimoto T, Shirouzu K, Yamada A, Todo S, Itoh K, Yamana H
- Journal Title
  
  Clinical Cancer Research 10(3)
  
  Pages: 929-937
- Data Source
  KAKENHI-PROJECT-16591286
[Journal Article] A phase I trial of Cytotoxic T-lymphocyte precursor-oriented peptide vaccines for colorectal carcinoma patients.2004
- Author(s)
  Sato Y, Maeda Y, Sasatomi T, Takahashi M, Une Y, Kondo M, Shinohara T, Hida N, Katagiri K, Sato K, Sato M, Yamada A, Yamana H, Itoh K, Todo S
- Journal Title
  
  British J. Cancer 90(7)
  
  Pages: 1334-1342
- Data Source
  KAKENHI-PROJECT-16591286
[Journal Article] Immunological evaluation of vaccination with pre-designated peptides frequently selected as vaccine candidates in an individualized peptide vaccination regimen. 24:121-131,20042004
- Author(s)
  Motizuki K, Sato Y, Tsuda N, Shoumura H, Sakamoto M, Matsuura K, Ushijima K, Maeda Y, Katagiri K, Yamada A, Todo S, Kamura T, Harada M, Itoh K
- Journal Title
  
  International J Oncology 24
  
  Pages: 121-131
- Data Source
  KAKENHI-PROJECT-16591286
[Journal Article] Identification of epidermal growth factor receptor-derived peptides recognized by both cellular and humoral immunities in HLA-A24+ non-small cell lung cancer patients2004
- Author(s)
  Shomura H, Shichijo S, Matsueda S, Mine T, Rikimaru T, Sato Y, Todo S, Itoh K
- Journal Title
  
  European J. Cancer 40(11)
  
  Pages: 1776-1786
- Data Source
  KAKENHI-PROJECT-16591286
[Journal Article] Identification of epidermal growth factor receptor-derived peptides immunogenic for HLA-A2+ cancer patients.2004
- Author(s)
  Shomura H, Shichijo S, Matsueda S, Kawakami T, Sato Y, Todo S, Itoh K
- Journal Title
  
  British J. Cancer 90(8)
  
  Pages: 1563-1571
- Data Source
  KAKENHI-PROJECT-16591286
[Journal Article] Randomized controlled study of immunochemotherapy with OK-432 after curative surgery for gastric cancer.2004
- Author(s)
  Sato Y, Kondo M, Kohashi S, Takahashi N, Takahashi S, Sinohara T, Ono K, Matsuda M, Ryoma Y, Shiroto H, Kondo Y, Uchino J., Saito K., Todo S
- Journal Title
  
  J Immunotherapy 27(5)
  
  Pages: 394-397
- Data Source
  KAKENHI-PROJECT-16591286

1. KONDO Masao (30333610)

# of Collaborated Projects: 2 results

# of Collaborated Products: 5 results
2. TODO Satoru (60136463)

# of Collaborated Projects: 2 results

# of Collaborated Products: 15 results

SATO Yuji 佐藤 裕二

Research Projects

Research Products

Co-Researchers

Study of prognostic prediction in stage III and IV gastric carcinoma by immunological evaluationPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

大腸癌肝筋移に対するインターフェロンβ geneを用いた免疫療法の開発

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Journal Article] Chemotheapy prediction in esopphageal cell carcinoma : Novel marker genes and efficacy-prediction formulae using expression data.2006

Author(s)

Journal Title

Description

Data Source

[Journal Article] Chemotheapy Prediction in esophageal cell carcinoma : Novel marker genes and efficacy-prediction formulae using expression data.2006

Author(s)

Journal Title

Description

Data Source

[Journal Article] Phase II study of Docetaxel and S-1 combination therapy for advanced or recurrent gastric cancer.2006

Author(s)

Journal Title

Description

Data Source

[Journal Article] squamous cell carcinoma antigen- reactive CTLs in HLA-A24+ cancer patient.2006

Author(s)

Journal Title

Description

Data Source

[Journal Article] Identification of squamous cell carcinoma antigen-reactive CTLs in HLA-A24+ cancer patient.2006

Author(s)

Journal Title

Description

Data Source

[Journal Article] Phase II study of Docetaxel and S-1 combination therapy for advanced or recurrent gastric cancer. 2006, in press2006

Author(s)

Journal Title

Description

Data Source

[Journal Article] Evidence of dual function of macrophage migration factor relevant to tumor progression and regression.2005

Author(s)

Journal Title

Description

Data Source

[Journal Article] Macrophage Migration Inhibitory Factor (MIF) promotes tumor invation and metastasis via the Rho-Dependent pathway.2005

Author(s)

Journal Title

Data Source

[Journal Article] Evidence of dual function of macrophage migration factor relevant to tumor progression and regression.2005

Author(s)

Journal Title

Description

Data Source

[Journal Article] Humoral Response to peptide correlate with over all survival in advanced cancer patients vaccinated with peptides based on pre-existing, peptide-specific cellular responses.2004

Author(s)

Journal Title

Data Source

[Journal Article] A phase I trial of Cytotoxic T-lymphocyte precursor-oriented peptide vaccines for colorectal carcinoma patients.2004

Author(s)

Journal Title

Data Source

[Journal Article] Immunological evaluation of vaccination with pre-designated peptides frequently selected as vaccine candidates in an individualized peptide vaccination regimen. 24:121-131,20042004

Author(s)

Journal Title

Data Source

[Journal Article] Identification of epidermal growth factor receptor-derived peptides recognized by both cellular and humoral immunities in HLA-A24+ non-small cell lung cancer patients2004

Author(s)

Journal Title

Data Source

[Journal Article] Identification of epidermal growth factor receptor-derived peptides immunogenic for HLA-A2+ cancer patients.2004

Author(s)

Journal Title

Data Source

SATO Yuji 佐藤裕二